The Bob Harrington Show Podcast Por Medscape arte de portada

The Bob Harrington Show

The Bob Harrington Show

De: Medscape
Escúchala gratis

The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine.Copyright 2019, Medscape Ciencia Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Bullish Optimism on AI and the Physician's Role in Medicine
    Mar 27 2026

    Drs Bob Harrington and Bob Wachter discuss the use of AI in healthcare, and Dr Wachter's latest book, A Giant Leap.

    This podcast is intended for healthcare professionals only.

    To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington

    A Giant Leap. How AI Is Transforming Healthcare and What That Means for Our Future

    https://www.penguinrandomhouse.com/books/776443/a-giant-leap-by-robert-wachter-md/

    Revisiting the Time Needed to Provide Adult Primary Care

    https://doi.org/10.1007/s11606-022-07707-x

    Bob Wachter, Digital Doctor Author, Interviewed

    https://www.medscape.com/viewarticle/848172

    Evidence based medicine: what it is and what it isn't

    https://doi.org/10.1136/bmj.312.7023.71

    Your A.I. Radiologist Will Not Be With You Soon

    https://www.nytimes.com/2025/05/14/technology/ai-jobs-radiologists-mayo-clinic.html

    What This Computer Needs Is a Physician: Humanism and Artificial Intelligence https://doi.org/10.1001/jama.2017.19198

    Reliability of LLMs as medical assistants for the general public: a randomized preregistered study

    https://doi.org/10.1038/s41591-025-04074-y

    Expressing stigma and inappropriate responses prevents LLMs from safely replacing mental health providers

    https://arxiv.org/abs/2504.18412

    Perceptions and Opinions of Patients About Mental Health Chatbots: Scoping Review

    https://doi.org/10.2196/17828

    User Intentions to Use ChatGPT for Self-Diagnosis and Health-Related Purposes: Cross-sectional Survey Study

    https://doi.org/10.2196/47564

    KFF Health Misinformation Tracking Poll: Artificial Intelligence and Health Information

    https://www.kff.org/public-opinion/kff-health-misinformation-tracking-poll-artificial-intelligence-and-health-information/

    You may also like:

    Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

    https://www.medscape.com/twic

    Questions or feedback, please contact news@medscape.net

    Más Menos
    27 m
  • Stroke, Dementia, Voodoo Death: The Heart-Brain Connection
    Jan 26 2026

    Cardiologist Bob Harrington talks to Mitch Elkind, chief science officer for Brain Health and Stroke at the AHA, about the heart-brain connection and why what's good for the brain is good for the heart.

    This podcast is intended for healthcare professionals only.

    To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington

    Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association https://www.ahajournals.org/doi/10.1161/CIR.0000000000001078

    Migraine Headache: An Under-Appreciated Risk Factor for Cardiovascular Disease in Women https://www.ahajournals.org/doi/10.1161/JAHA.119.014546

    Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands

    https://doi.org/10.1080/13814788.2017.1398318

    Characteristics and treatment of midlife-onset epilepsy: A 24-year single-center, retrospective study

    https://doi.org/10.1002/epd2.20253

    Traumatic Brain Injury and Risk of Neurodegenerative Disorder

    https://doi.org/10.1016/j.biopsych.2021.05.025

    Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence

    https://doi.org/10.3390/ijms222413488

    The neuropathological diagnosis of Alzheimer's disease

    https://doi.org/10.1186/s13024-019-0333-5

    Failed Semaglutide for Early Alzheimer's Not the End of the Road?

    https://www.medscape.com/viewarticle/failed-semaglutide-early-alzheimers-not-end-road-2025a1000y4l

    Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration

    https://doi.org/10.1161/circulationaha.121.055018

    Reduced regional cerebral blood flow in patients with heart failure

    https://doi.org/10.1002/ejhf.874

    Heart-brain Interactions in Heart Failure

    https://doi.org/10.15420/cfr.2018.14.2

    While You Were Sleeping, the Brain's 'Waste Disposal System' Was at Work

    https://www.medscape.com/viewarticle/while-you-were-sleeping-brains-waste-disposal-system-was-2025a1000mbb

    Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder

    https://doi.org/10.1001/jamapsychiatry.2024.3599

    2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://www.ahajournals.org/doi/10.1161/CIR.0000000000001356

    "VOODOO" Death https://ajph.aphapublications.org/doi/full/10.2105/AJPH.92.10.1593

    Longitudinal brain ageing after stroke: a marker for neurodegeneration and its relevance for upper limb motor outcome https://doi.org/10.1093/braincomms/fcaf299

    Unlocking Longevity: Aging Reimagined https://www.medscape.com/viewarticle/1002241

    You may also like:

    Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

    https://www.medscape.com/twic

    Questions or feedback, please contact news@medscape.net

    Más Menos
    24 m
  • Cardiovascular Medicine 2025 Wrapped: The Big Picture
    Dec 30 2025

    Drs Harrington and Gibson's annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ever lower LDL-C with drugs or even gene editing are among the highlights.

    This podcast is intended for healthcare professionals only.

    To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington

    New ACS Guidelines

    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes

    https://doi.org/10.1161/CIR.0000000000001309

    ACS Guideline Chair and Vice-Chair Discussion

    https://www.medscape.com/viewarticle/acs-guidelines-2025-key-points-chair-and-vice-chair-2025a100093l

    Antiplatelet/Antithrombotic Strategies

    Prasugrel Beats Ticagrelor in High-Risk Patients With Diabetes After PCI

    https://www.medscape.com/viewarticle/prasugrel-beats-ticagrelor-high-risk-patients-diabetes-after-2025a1000wbt

    Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes (NEO-MINDSET)

    https://www.nejm.org/doi/full/10.1056/NEJMoa2507980

    Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC)

    https://www.nejm.org/doi/full/10.1056/NEJMoa2507532

    Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making : ENGAGE AF-TIMI 48 Trial Analysis

    https://doi.org/10.1016/j.jacadv.2025.102504

    Factor XI Inhibitors

    Bristol Myers, J&J Stop Blood Clotting Drug Trial After Interim Review

    https://www.medscape.com/s/viewarticle/bristol-myers-j-j-stop-blood-clotting-drug-trial-after-2025a1000vqu

    Bayer's Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention https://www.bayer.com/en/us/news-stories/oceanic-stroke

    OAC-Naive Subgroup From OCEANIC-AF Published

    https://www.medscape.com/viewarticle/novel-blood-thinner-shows-promise-atrial-fibrillation-2025a10008lz

    GLP-1 and Myotrophic Drugs

    Lilly's Next-gen Drug Shows Greater Weight Loss Than Zepbound in Late-stage Trial (TRIUMPH-4)

    https://www.medscape.com/s/viewarticle/lillys-next-gen-drug-tops-zepbound-weight-loss-late-stage-2025a1000ys1

    Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial

    https://www.medscape.com/viewarticle/amylin-analog-eloralintide-reduces-weight-phase-2-trial-2025a1000uqf

    CRISPR and Lipid Lowering

    Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease

    https://www.nejm.org/doi/full/10.1056/NEJMoa2504747

    Gene Therapy Shows Lipid Improvement but Raises Flags

    https://www.medscape.com/viewarticle/gene-therapy-shows-lipid-improvement-raises-flags-2025a1000uzw

    Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3

    https://www.nejm.org/doi/full/10.1056/NEJMoa2511778

    Evolocumab in Patients without a Previous Myocardial Infarction or Stroke (VESALIUS-CV)

    https://www.nejm.org/doi/pdf/10.1056/NEJMoa2514428

    Prehospital GLP IIb/IIIa

    Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction (CELEBRATE) https://evidence.nejm.org/doi/full/10.1056/EVIDoa2500268

    You may also like:

    Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

    https://www.medscape.com/twic

    Questions or feedback, please contact news@medscape.net

    Más Menos
    32 m
Todavía no hay opiniones